| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Janusz Rybakowsk. Sixty years of recurrence prevention in mood disorders. Psychiatria polska. vol 58. issue 2. 2024-07-14. PMID:39003507. |
since the mid-1990s, 2nd generation of mood-stabilizing drugs has been introduced, including some atypical antipsychotics (clozapine, olanzapine, quetiapine, aripiprazole, risperidone) and anticonvulsant drug, lamotrigine, showing prophylactic activity in bipolar mood disorder. |
2024-07-14 |
2024-07-16 |
Not clear |
| Matteo Moroni, Eduardo Bruer. Tongue edema as an adverse drug reaction to low-dose olanzapine in a cancer patient receiving palliative care. Palliative & supportive care. 2024-04-02. PMID:38562098. |
olanzapine is an atypical neuroleptic indicated for treatment of various psychiatric disorders, but it has also several indications in palliative care (pc) patients: opioids misuse, nausea not related to chemotherapy, anorexia-cachexia syndrome, and sleep and mood disorders. |
2024-04-02 |
2024-04-04 |
Not clear |
| Magdalena Świądro-Piętoń, Dominika Dudek, Renata Wietecha-Posłuszn. Direct Immersion-Solid Phase Microextraction for Therapeutic Drug Monitoring of Patients with Mood Disorders. Molecules (Basel, Switzerland). vol 29. issue 3. 2024-02-10. PMID:38338419. |
it has been adapted to identify the most commonly used drugs in mood disorders, including amitriptyline, citalopram, fluoxetine, paroxetine, sertraline, trazodone, duloxetine, venlafaxine, lamotrigine, quetiapine, olanzapine, and mirtazapine. |
2024-02-10 |
2024-02-12 |
Not clear |
| Doaa Ghorab, Ejlal M Abu-El-Rub, Mohamed Hamdi Gharaibeh, Alaa Yehya, Ramada R Khasawneh, Laila M Matalqah, Ahmed Mohamed Helal. Neurological Effects of Combining Low Toxic Dose of Tramadol and Nicotine: An Animal Model Evidence of Endoplasmic Reticulum Stress. BioMed research international. vol 2023. 2023-08-18. PMID:37593523. |
serotonin receptor blockers such as olanzapine may increase systemic serotonin levels and need further investigation to utterly pinpoint their roles in managing mood disorders. |
2023-08-18 |
2023-09-07 |
rat |
| Robin H Isaacson, Juliane I Beier, Nicholas Kh Khoo, Bruce A Freeman, Zachary Freyberg, Gavin E Artee. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane. The Journal of nutritional biochemistry. vol 81. 2021-04-20. PMID:32388251. |
olanzapine is effective to treat for schizophrenia and other mood disorders, but limited by side effects such as weight gain, dyslipidemia, and liver injury. |
2021-04-20 |
2023-08-13 |
mouse |
| W Clay Jackson, J Sloan Manning, Pamela D Connor, O Greg Deardorf. Retrospective Study of Olanzapine in Depressive and Anxious States in Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 6. issue 5. 2020-09-29. PMID:15514689. |
method: a retrospective chart review was conducted for all identifiable patients prescribed olanzapine for mood disorders (dsm-iv) during a 3-year period (july 1998-july 2001), utilizing clinician and nurse recall, sampling of general continuity clinic records, and a hand search of mood disorder clinic records. |
2020-09-29 |
2023-08-12 |
Not clear |
| W Clay Jackson, J Sloan Manning, Pamela D Connor, O Greg Deardorf. Retrospective Study of Olanzapine in Depressive and Anxious States in Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 6. issue 5. 2020-09-29. PMID:15514689. |
conclusion: olanzapine shows promise as an effective pharmacotherapeutic agent for primary care patients with mood disorders that lie along the bipolar spectrum or that are resistant to treatment with antidepressant monotherapies, but is associated with mild-to-moderate weight gain. |
2020-09-29 |
2023-08-12 |
Not clear |
| Hasan Bozkurt, Serkan Şahi. Olanzapine-induced Priapism in a Child with Asperger's Syndrome. Balkan medical journal. vol 34. issue 1. 2018-06-11. PMID:28251031. |
olanzapine has been reported to induce priapism in several adult cases with schizophrenia and/or mood disorders but very rarely reported in children. |
2018-06-11 |
2023-08-13 |
Not clear |
| N Pang, N Thrichelvam, K O Nain. Olanzapine-induced Pancytopenia: A Rare but Worrying Complication. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan. vol 27. issue 1. 2017-08-04. PMID:28387211. |
a diagnosis of schizophrenia was made in the absence of any suggestive features of mood disorders, substance abuse or organicity, and olanzapine as second-line treatment. |
2017-08-04 |
2023-08-13 |
Not clear |
| Hua Jin, Pei-an Betty Shih, Shahrokh Golshan, Sunder Mudaliar, Robert Henry, Danielle K Glorioso, Stephan Arndt, Helena C Kraemer, Dilip V Jest. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. The Journal of clinical psychiatry. vol 74. issue 1. 2013-04-15. PMID:23218100. |
to compare longer-term safety and effectiveness of the 4 most commonly used atypical antipsychotics (aripiprazole, olanzapine, quetiapine, and risperidone) in 332 patients, aged > 40 years, having psychosis associated with schizophrenia, mood disorders, posttraumatic stress disorder, or dementia, diagnosed using dsm-iv-tr criteria. |
2013-04-15 |
2023-08-12 |
Not clear |
| Charles A Pastor, Monica Meht. Masked clozapine-induced cardiomyopathy. Journal of the American Board of Family Medicine : JABFM. vol 21. issue 1. 2008-03-20. PMID:18178706. |
a 33-year-old latin-american woman with a history of psychosis and mood disorder, but no cardiac history or risk factors, presented with heart failure after 6 weeks of clozapine and olanzapine therapy. |
2008-03-20 |
2023-08-12 |
Not clear |
| S Hossein Fatemi, Teri J Reutiman, Timothy D Folsom, Christopher Bell, Lisa Nos, Peter Fried, David A Pearce, Sushmita Singh, David P Siderovski, Francis S Willard, Mitsunori Fukud. Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 9. 2006-09-28. PMID:16407901. |
we hypothesized that chronic administration of olanzapine to rats would alter expression of various genes that may be involved in the etiology of schizophrenia and mood disorders. |
2006-09-28 |
2023-08-12 |
human |
| Benjamin L Handen, Antonio Y Harda. Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavioral disorders. Journal of the American Academy of Child and Adolescent Psychiatry. vol 45. issue 8. 2006-09-08. PMID:16865035. |
olanzapine, an atypical antipsychotic, has been shown to be efficacious for treatment of psychotic and mood disorders in adults. |
2006-09-08 |
2023-08-12 |
Not clear |
| Peter F Buckle. Olanzapine: a critical review of recent literature. Expert opinion on pharmacotherapy. vol 6. issue 12. 2006-06-01. PMID:16197360. |
new information continues to emerge on the impact of olanzapine on schizophrenia and on aspects of the course of mood disorders. |
2006-06-01 |
2023-08-12 |
Not clear |
| Peter F Buckle. Olanzapine: a critical review of recent literature. Expert opinion on pharmacotherapy. vol 6. issue 12. 2006-06-01. PMID:16197360. |
the purpose of this review is to critically review the current literature on olanzapine with an emphasis on emergent themes and key findings in the use of this agent for the treatment of mood disorders and schizophrenia. |
2006-06-01 |
2023-08-12 |
Not clear |
| Richard C Shelto. The combination of olanzapine and fluoxetine in mood disorders. Expert opinion on pharmacotherapy. vol 4. issue 7. 2003-08-19. PMID:12831342. |
the combination of olanzapine and fluoxetine in mood disorders. |
2003-08-19 |
2023-08-12 |
Not clear |
| Kumar Budur, Leo Pozuel. Olanzapine for corticosteroid-induced mood disorders. Psychosomatics. vol 44. issue 4. 2003-08-19. PMID:12832608. |
olanzapine for corticosteroid-induced mood disorders. |
2003-08-19 |
2023-08-12 |
Not clear |
| Larry S Goldman, Joseph Govea. Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics. vol 43. issue 6. 2003-03-21. PMID:12444234. |
olanzapine treatment of corticosteroid-induced mood disorders. |
2003-03-21 |
2023-08-12 |
Not clear |
| R Narendran, C M Young, A M Valenti, C A Pristach, M T Pato, J J Grac. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. The Journal of clinical psychiatry. vol 62. issue 7. 2001-09-06. PMID:11488360. |
olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. |
2001-09-06 |
2023-08-12 |
Not clear |
| R Narendran, C M Young, A M Valenti, C A Pristach, M T Pato, J J Grac. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. The Journal of clinical psychiatry. vol 62. issue 7. 2001-09-06. PMID:11488360. |
the purpose of this naturalistic study was to determine the long-term effectiveness and tolerability of olanzapine as add-on therapy in psychotic mood disorders. |
2001-09-06 |
2023-08-12 |
Not clear |